Researchers Question Wide Use of HPV Vaccines

Two vaccines against cervical cancer are being widely used without sufficient evidence about whether they are worth their high cost or even whether they will effectively stop women from getting the disease, two articles in this week’s New England Journal of Medicine conclude ... “Despite great expectations and promising results of clinical trials, we still lack sufficient evidence of an effective vaccine against cervical cancer,” Dr. Charlotte J. Haug, editor of The Journal of the Norwegian Medical Association, wrote in an editorial in Thursday’s issue of The New England Journal. “With so many essential questions still unanswered, there is good reason to be cautious.”

Popular posts from this blog

The January 6th Capitol Hill Riot, Censorship and Related Issues Resource List

U.S. Election Fraud Resource List

COVID-Coronavirus Pandemic, Lockdowns and Vaccines Resource List